Grabner G, et al. Am J Ophthalmol. 2015;doi:10.1016/j.ajo.2015.08.017.

December 21, 2015
1 min read

IC-8 IOL may improve range of focal distances in cataract patients


Grabner G, et al. Am J Ophthalmol. 2015;doi:10.1016/j.ajo.2015.08.017.

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

Small-aperture technology in an IOL implanted monocularly may effectively improve a broad range of vision in presbyopic patients who require cataract surgery, according to a study.

The prospective, noncomparative multicenter case series investigated the visual performance of 12 cataract surgery patients implanted monocularly with the small-aperture hydrophobic IC-8 IOL (AcuFocus).

Mean monocular uncorrected near, intermediate and distance visual acuity improved significantly from 0.66 ± 0.23, 0.52 ± 0.22 and 0.42 ± 0.18 preoperatively to 0.13 ± 0.15 (P < .0001), 0.09 ± 0.12 (P = .0002) and 0.03 ± 0.10 (P < .0001), respectively, at 12 months.

Additionally, all patients achieved uncorrected distance and intermediate visual acuity of 20/32 or better monocularly and binocularly, while 83% of patients achieved the same uncorrected near visual acuity monocularly and 92% binocularly at month 12.

All eyes had 20/40 or better visual acuity over a defocus range of +0.5 D to –1.5 D.

According to a patient questionnaire, blurry/fluctuating vision was significantly better at the 3-, 6- and 12-month follow-ups, and glare was significantly lower at 12 months postoperatively.

Next, a CE-marked injector designed for the IC-8 IOL will allow implantation through a 3.5- mm incision, rather than 6 mm, to reduce induction of astigmatism, the study said. – by Kristie L. Kahl

Disclosure: Grabner and Ang report they are clinical investigators for AcuFocus, and Vilupuru reports she is employed by AcuFocus.